Background
The ‘579 patent is directed to ‘[s]ystems for preparing patient-specific doses and method for telepharmacy in which data captured while following [a protocol associated with each received drug order and specifying a set of steps to fill the drug order] are provided to a remote site for review and approval by a pharmacist.’
Becton’s Appeal
Becton, Dickinson and Company appealed the decision from the Patent Trial and Appeal Board, determining that certain claims of U.S. Patent No. 8,554,579 were not invalid as obvious.
The parties agree that claims 1 and 8 of the ‘579 patent are illustrative, with two contested limitations on appeal: the “verification” limitation and the “highlighting” limitation.
Manual:
Chat: Powered By VoiceSphere